Developments in the formulation and delivery of spray dried vaccines

References

• Kumru OS , Joshi SB , Smith DE , Middaugh CR , Prusik T , Volkin DB. Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies. Biologicals. 2014;42(5):237–59. doi:10.1016/j.biologicals.2014.05.007. PMID:24996452
   PubMed Web of Science ®Google Scholar
• Brandau DT , Jones LS , Wiethoff CM , Rexroad J , Middaugh CR . Thermal stability of vaccines. J Pharm Sci. 2003;92(2):218–31. doi:10.1002/jps.10296. PMID:12532371
   PubMed Web of Science ®Google Scholar
• Zaffran M . Vaccine transport and storage: Environmental challenges. Dev Biol Stand. 1996;87:9–17. PMID:8853997
   PubMedGoogle Scholar
• Chen D , Kristensen D . Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines. 2009;8(5):547–57. doi:10.1586/erv.09.20. PMID:19397412
   PubMed Web of Science ®Google Scholar
• Organization WHO . Monitoring vaccine wastage at country level: Guidelines for programmme managers 2005. http://www.who.int/iris/handle/10665/68463
   Google Scholar
• Maltesen MJ , van de Weert M . Drying methods for protein pharmaceuticals. Drug Discov Today Technol. 2008;5(2–3):e81–8. doi:10.1016/j.ddtec.2008.11.001. PMID:24981095
   PubMedGoogle Scholar
• Geeraedts F , Saluja V , ter Veer W , Amorij JP , Frijlink HW , Wilschut J , Hinrichs WL , Huckriede A . Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures. AAPS J. 2010;12(2):215–22. doi:10.1208/s12248-010-9179-z. PMID:20195930
   PubMed Web of Science ®Google Scholar
• Amorij JP , Huckriede A , Wilschut J , Frijlink HW , Hinrichs WL . Development of stable influenza vaccine powder formulations: Challenges and possibilities. Pharm Res. 2008;25(6):1256–73. doi:10.1007/s11095-008-9559-6. PMID:18338241
   PubMed Web of Science ®Google Scholar
• Adams G . The principles of freeze-drying. Methods Mol Biol. 2007;368:15–38. doi:10.1007/978-1-59745-362-2_2. PMID:18080460
   PubMedGoogle Scholar
• Greb E . Is spray drying a viable alternative to lyophilization? Equipment and Processing Report; 2009. Epub Dec 16, 2009.
   Google Scholar
• Kanojia G , Willems GJ , Frijlink HW , Kersten GF , Soema PC , Amorij JP . A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine. Int J Pharm. 2016;511(2):1098–111. doi:10.1016/j.ijpharm.2016.08.022. PMID:27523619
   PubMed Web of Science ®Google Scholar
• Zhu C , Shoji Y , McCray S , Burke M , Hartman CE , Chichester JA , Breit J , Yusibov V , Chen D , Lal M . Stabilization of HAC1 influenza vaccine by spray drying: Formulation development and process scale-up. Pharm Res. 2014;31:3006–18. doi:10.1007/s11095-014-1394-3. PMID:24858396
   PubMed Web of Science ®Google Scholar
• Roy I , Gupta MN . Freeze-drying of proteins: Some emerging concerns. Biotechnol Appl Biochem. 2004;39(Pt 2):165–77. doi:10.1042/BA20030133. PMID:15032737
   PubMed Web of Science ®Google Scholar
• Katja S . Spray drying of protein precipitates and evaluation of the nano spray dryer B-90 [Dissertation]. LMU Munich; 2011.
   Google Scholar
• Vehring R . Pharmaceutical particle engineering via spray drying. Pharm Res. 2008;25(5):999–1022. doi:10.1007/s11095-007-9475-1. PMID:18040761
   PubMed Web of Science ®Google Scholar
• Masters K . Spray drying handbook. 5th ed. Burnt Mill, Harlow, Essex, England New York: Longman Scientific & Technical; Wiley; 1991. xiv, 725.
   Google Scholar
• Gala RP , Popescu C , Knipp GT , McCain RR , Ubale RV , Addo R , Bhowmik T, Kulczar CD, D'Souza MJ. Physicochemical and preclinical evaluation of a novel buccal measles vaccine. AAPS PharmSciTech. 2016;18(2):283–292. doi:10.1016/j.ijpharm.2015.04.053. PMID:27357420
   PubMed Web of Science ®Google Scholar
• Wanning S , Suverkrup R , Lamprecht A . Pharmaceutical spray freeze drying. Int J Pharm. 2015;488(1–2):136–53. PMID:25900097
   PubMed Web of Science ®Google Scholar
• Maa YF , Zhao L , Payne LG , Chen D . Stabilization of alum-adjuvanted vaccine dry powder formulations: Mechanism and application. J Pharm Sci. 2003;92(2):319–32. doi:10.1002/jps.10294. PMID:12532382
   PubMed Web of Science ®Google Scholar
• Dean HJ , Chen D . Epidermal powder immunization against influenza. Vaccine. 2004;23(5):681–6. doi:10.1016/j.vaccine.2004.06.041. PMID:15542190
   PubMed Web of Science ®Google Scholar
• Saluja V , Amorij JP , Kapteyn JC , de Boer AH , Frijlink HW , Hinrichs WL . A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. J Control Release. 2010;144(2):127–33. doi:10.1016/j.jconrel.2010.02.025. PMID:20219608
   PubMed Web of Science ®Google Scholar
• Amorij JP , Saluja V , Petersen AH , Hinrichs WL , Huckriede A , Frijlink HW . Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine. 2007;25(52):8707–17. doi:10.1016/j.vaccine.2007.10.035. PMID:17996993
   PubMed Web of Science ®Google Scholar
• Maa YF , Shu C , Ameri M , Zuleger C , Che J , Osorio JE , Payne LG , Chen D . Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization. Pharm Res. 2003;20(7):969–77. doi:10.1023/A:1024493719236. PMID:12880281
   PubMed Web of Science ®Google Scholar
• Tonnis WF , Amorij JP , Vreeman MA , Frijlink HW , Kersten GF , Hinrichs WL . Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars. Eur J Pharm Sci. 2014;55:36–45. doi:10.1016/j.ejps.2014.01.005. PMID:24468629
   PubMed Web of Science ®Google Scholar
• Mikszta JA , Sullivan VJ , Dean C , Waterston AM , Alarcon JB , Dekker JP 3rd , Brittingham JM , Huang J , Hwang CR , Ferriter M , et al. Protective immunization against inhalational anthrax: A comparison of minimally invasive delivery platforms. J Infect Dis. 2005;191(2):278–88. doi:10.1086/426865. PMID:15609239
   PubMed Web of Science ®Google Scholar
• Wang SH , Kirwan SM , Abraham SN , Staats HF , Hickey AJ . Stable dry powder formulation for nasal delivery of anthrax vaccine. J Pharm Sci. 2012;101(1):31–47. doi:10.1002/jps.22742. PMID:21905034
   PubMed Web of Science ®Google Scholar
• Huang J , D'Souza AJ , Alarcon JB , Mikszta JA , Ford BM , Ferriter MS , Evans M , Stewart T , Amemiya K , Ulrich RG , et al. Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine. Clin Vaccine Immunol. 2009;16(5):719–25. doi:10.1128/CVI.00447-08. PMID:19261773
   PubMed Web of Science ®Google Scholar
• Jovanovic N , Bouchard A , Hofland GW , Witkamp GJ , Crommelin DJ , Jiskoot W . Stabilization of proteins in dry powder formulations using supercritical fluid technology. Pharm Res. 2004;21(11):1955–69. doi:10.1023/B:PHAM.0000048185.09483.e7. PMID:15587916
   PubMed Web of Science ®Google Scholar
• Sievers RE , Karst U . Inventor Methods for fine particle formation 1997 June 17. Patent US5639441 A.
   Google Scholar
• Sievers RESPS , Carpenter JF . inventorSupercritical fluid-assisted nebulization and bubble drying 2003 October 7. Patent US 6630121 B1.
   Google Scholar
• Cape SP , Villa JA , Huang ET , Yang TH , Carpenter JF , Sievers RE . Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids. Pharm Res. 2008;25(9):1967–90. doi:10.1007/s11095-008-9575-6. PMID:18581212
   PubMed Web of Science ®Google Scholar
• Sellers SP , Clark GS , Sievers RE , Carpenter JF . Dry powders of stable protein formulations from aqueous solutions prepared using supercritical CO(2)-assisted aerosolization. J Pharm Sci. 2001;90(6):785–97. doi:10.1002/jps.1032. PMID:11357179
   PubMed Web of Science ®Google Scholar
• Burger JL , Cape SP , Braun CS , McAdams DH , Best JA , Bhagwat P , Pathak P , Rebits LG , Sievers RE . Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine. J Aerosol Med Pulm drug deliv. 2008;21(1):25–34. doi:10.1089/jamp.2007.0658. PMID:18518829
   PubMed Web of Science ®Google Scholar
• Kissmann J , Ausar SF , Rudolph A , Braun C , Cape SP , Sievers RE , Federspiel MJ , Joshi SB , Middaugh CR . Stabilization of measles virus for vaccine formulation. Hum Vaccin. 2008;4(5):350–9. doi:10.4161/hv.4.5.5863. PMID:18382143
   PubMed Web of Science ®Google Scholar
• LeClair DA , Cranston ED , Xing Z , Thompson MR . Optimization of spray drying conditions for yield, particle size and biological activity of thermally stable viral vectors. Pharm Res. 2016;33(11):2763–76. doi:10.1007/s11095-016-2003-4. PMID:27450412
   PubMed Web of Science ®Google Scholar
• Grasmeijer N . Improving protein stabilization by spray drying [PhD thesis]. University of Groningen; 2016.
   Google Scholar
• Maa YF , Prestrelski SJ . Biopharmaceutical powders: Particle formation and formulation considerations. Curr Pharm Biotechnol. 2000;1(3):283–302. doi:10.2174/1389201003378898. PMID:11469385
   PubMedGoogle Scholar
• Webb SD , Golledge SL , Cleland JL , Carpenter JF , Randolph TW . Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations. J Pharm Sci. 2002;91(6):1474–87. doi:10.1002/jps.10135. PMID:12115847
   PubMed Web of Science ®Google Scholar
• Mumenthaler M , Hsu CC , Pearlman R . Feasibility study on spray-drying protein pharmaceuticals: Recombinant human growth hormone and tissue-type plasminogen activator. Pharm Res. 1994;11(1):12–20. doi:10.1023/A:1018929224005. PMID:8140042
   PubMed Web of Science ®Google Scholar
• Ohtake S , Martin RA , Yee L , Chen D , Kristensen DD , Lechuga-Ballesteros D , Truong-Le V . Heat-stable measles vaccine produced by spray drying. Vaccine. 2010;28(5):1275–84. doi:10.1016/j.vaccine.2009.11.024. PMID:19944152
   PubMed Web of Science ®Google Scholar
• Stahl K , Claesson M , Lilliehorn P , Linden H , Backstrom K . The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. Int J Pharm. 2002;233(1–2):227–37. doi:10.1016/S0378-5173(01)00945-0. PMID:11897427
   PubMed Web of Science ®Google Scholar
• Maltesen MJ , Bjerregaard S , Hovgaard L , Havelund S , van de Weert M . Quality by design - Spray drying of insulin intended for inhalation. Eur J Pharm Biopharm. 2008;70(3):828–38. doi:10.1016/j.ejpb.2008.07.015. PMID:18755270
   PubMed Web of Science ®Google Scholar
• Rabbani NR , Seville PC . The influence of formulation components on the aerosolisation properties of spray-dried powders. J Control Release. 2005;110(1):130–40. doi:10.1016/j.jconrel.2005.09.004. PMID:16226334
   PubMed Web of Science ®Google Scholar
• Wong YL , Sampson S , Germishuizen WA , Goonesekera S , Caponetti G , Sadoff J , Bloom BR , Edwards D . Drying a tuberculosis vaccine without freezing. Proc Natl Acad Sci U S A. 2007;104(8):2591–5. doi:10.1073/pnas.0611430104. PMID:17299039
   PubMed Web of Science ®Google Scholar
• Lin WH , Griffin DE , Rota PA , Papania M , Cape SP , Bennett D , Quinn B , Sievers RE , Shermer C , Powell K , et al. Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques. Proc Natl Acad Sci U S A. 2011;108(7):2987–92. doi:10.1073/pnas.1017334108. PMID:21282608
   PubMed Web of Science ®Google Scholar
• Lovalenti PM , Anderl J , Yee L , Nguyen V , Ghavami B , Ohtake S , Saxena A , Voss T , Truong-Le V . Stabilization of live attenuated influenza vaccines by freeze drying, spray drying, and foam drying. Pharm Res. 2016;33:1144–60. doi:10.1007/s11095-016-1860-1. PMID:26818839
   PubMed Web of Science ®Google Scholar
• Sou T , Morton DA , Williamson M , Meeusen EN , Kaminskas LM , McIntosh MP . Spray-Dried influenza antigen with trehalose and leucine produces an aerosolizable powder vaccine formulation that induces strong systemic and mucosal immunity after pulmonary administration. J Aerosol Med Pulm Drug Deliv. 2015;28:361–71. doi:10.1089/jamp.2014.1176. PMID:25714115
   PubMed Web of Science ®Google Scholar
• Garcia-Contreras L , Wong YL , Muttil P , Padilla D , Sadoff J , Derousse J , Germishuizen WA , Goonesekera S , Elbert K , Bloom BR , et al. Immunization by a bacterial aerosol. Proc Natl Acad Sci U S A. 2008;105(12):4656–60. doi:10.1073/pnas.0800043105. PMID:18344320
   PubMed Web of Science ®Google Scholar
• Jin TH , Tsao E , Goudsmit J , Dheenadhayalan V , Sadoff J . Stabilizing formulations for inhalable powders of an adenovirus 35-vectored tuberculosis (TB) vaccine (AERAS-402). Vaccine. 2010;28(27):4369–75. doi:10.1016/j.vaccine.2010.04.059. PMID:20444437
   PubMed Web of Science ®Google Scholar
• Tyne AS , Chan JG , Shanahan ER , Atmosukarto I , Chan HK , Britton WJ , West NP . TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines. Vaccine. 2013;31(40):4322–9. doi:10.1016/j.vaccine.2013.07.022. PMID:23880366
   PubMed Web of Science ®Google Scholar
• Lu D , Garcia-Contreras L , Xu D , Kurtz SL , Liu J , Braunstein M , McMurray DN , Hickey AJ . Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B. Pharm Res. 2007;24(10):1834–43. doi:10.1007/s11095-007-9302-8. PMID:17657598
   PubMed Web of Science ®Google Scholar
• Lu D , Garcia-Contreras L , Muttil P , Padilla D , Xu D , Liu J , Braunstein M , McMurray DN , Hickey AJ . Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity. AAPS J. 2010;12(3):338–47. doi:10.1208/s12248-010-9193-1. PMID:20422340
   PubMed Web of Science ®Google Scholar
• Muttil P , Prego C , Garcia-Contreras L , Pulliam B , Fallon JK , Wang C , Hickey AJ , Edwards D . Immunization of guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary route. AAPS J. 2010;12(3):330–7. doi:10.1208/s12248-010-9192-2. PMID:20419360
   PubMed Web of Science ®Google Scholar
• Tawde SA , Chablani L , Akalkotkar A , D'Souza MJ . Evaluation of microparticulate ovarian cancer vaccine via transdermal route of delivery. J Control Release. 2016;235:147–54. doi:10.1016/j.jconrel.2016.05.058. PMID:27238440
   PubMed Web of Science ®Google Scholar
• Saboo S , Tumban E , Peabody J , Wafula D , Peabody DS , Chackerian B , Muttil P . Optimized formulation of a thermostable spray-dried virus-like particle vaccine against human papillomavirus. Mol Pharm. 2016;13(5):1646–55. doi:10.1021/acs.molpharmaceut.6b00072. PMID:27019231
   PubMed Web of Science ®Google Scholar
• Peabodya J , Muttil P , Chackeriana B , Tumban E . Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature. Papillomavirus Res. 2017;10(3):116–20. doi:10.1016/j.pvr.2017.03.004
   Web of Science ®Google Scholar
• LeClair DA , Cranston ED , Xing Z , Thompson MR . Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying. Int J Pharm. 2016;506(1–2):289–301. doi:10.1016/j.ijpharm.2016.04.067. PMID:27130366
   PubMed Web of Science ®Google Scholar
• Afkhami S , LeClair DA , Haddadi S , Lai R , Toniolo SP , Ertl HC , Cranston ED , Thompson MR , Xing Z . Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo. Vaccine. 2017;35:2916–24. doi:10.1016/j.vaccine.2017.04.026. PMID:28438408
   PubMed Web of Science ®Google Scholar
• Pastor M , Esquisabel A , Marquinez I , Talavera A , Pedraz JL . Cellulose acetate phthalate microparticles containing Vibrio cholerae: Steps toward an oral cholera vaccine. J Drug Target. 2014;22(6):478–87. doi:10.3109/1061186X.2014.888071. PMID:24731056
   PubMed Web of Science ®Google Scholar
• Ano G , Esquisabel A , Pastor M , Talavera A , Cedre B , Fernandez S , Sifontes S , Aranguren Y , Falero G , García L , et al. A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae. Vaccine. 2011;29(34):5758–64. doi:10.1016/j.vaccine.2011.05.098. PMID:21683110
   PubMed Web of Science ®Google Scholar
• Muttil P , Pulliam B , Garcia-Contreras L , Fallon JK , Wang C , Hickey AJ , Edwards DA . Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses. AAPS J. 2010;12(4):699–707. doi:10.1208/s12248-010-9229-6. PMID:20878294
   PubMed Web of Science ®Google Scholar
• Jones RM , Burke M , Dubose D , Chichester JA , Manceva S , Horsey A , Streatfield SJ , Breit J , Yusibov V . Stability and pre-formulation development of a plant-produced anthrax vaccine candidate. Vaccine. 2017;35(41):5463–5470. doi:10.1016/j.vaccine.2016.12.009
   PubMed Web of Science ®Google Scholar
• Chen D , Kapre S , Goel A , Suresh K , Beri S , Hickling J , Jensen J , Lal M , Preaud JM , Laforce M , et al. Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method. Vaccine. 2010;28(31):5093–9. doi:10.1016/j.vaccine.2010.04.112. PMID:20478345
   PubMed Web of Science ®Google Scholar
• Anish C , Upadhyay AK , Sehgal D , Panda AK . Influences of process and formulation parameters on powder flow properties and immunogenicity of spray dried polymer particles entrapping recombinant pneumococcal surface protein A. Int J Pharm. 2014;466(1–2):198–210. doi:10.1016/j.ijpharm.2014.03.025. PMID:24631054
   PubMed Web of Science ®Google Scholar
• Kunda NK , Alfagih IM , Miyaji EN , Figueiredo DB , Goncalves VM , Ferreira DM , Dennison SR , Somavarapu S , Hutcheon GA , Saleem IY . Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles. Int J Pharm. 2015;495(2):903–12. doi:10.1016/j.ijpharm.2015.09.034. PMID:26387622
   PubMed Web of Science ®Google Scholar
• Grasmeijer N , Stankovic M , de Waard H , Frijlink HW , Hinrichs WL . Unraveling protein stabilization mechanisms: Vitrification and water replacement in a glass transition temperature controlled system. Biochim Biophys Acta. 2013;1834(4):763–9. doi:10.1016/j.bbapap.2013.01.020. PMID:23360765
   PubMed Web of Science ®Google Scholar
• Crowe JH , Crowe LM , Chapman D . Preservation of membranes in anhydrobiotic organisms: The role of trehalose. Science. 1984;223(4637):701–3. doi:10.1126/science.223.4637.701. PMID:17841031
   PubMed Web of Science ®Google Scholar
• Schule S , Schulz-Fademrecht T , Garidel P , Bechtold-Peters K , Frieb W . Stabilization of IgG1 in spray-dried powders for inhalation. Eur J Pharm Biopharm. 2008;69(3):793–807. doi:10.1016/j.ejpb.2008.02.010. PMID:18477504
   PubMed Web of Science ®Google Scholar
• Aschenbrenner M , Grammueller E , Kulozik U , Foerst P . The contribution of the inherent restricted mobility of glassy sugar matrices to the overall stability of freeze-dried bacteria determined by low-resolution solid-state 1H-NMR. Food Bioproc Tech. 2014;7(4):1012–24. doi:10.1007/s11947-013-1095-7
   Web of Science ®Google Scholar
• Carpenter JF , Crowe JH . An infrared spectroscopic study of the interactions of carbohydrates with dried proteins. Biochemistry. 1989;28(9):3916–22. doi:10.1021/bi00435a044. PMID:2526652
   PubMed Web of Science ®Google Scholar
• Kunda NK , Wafula D , Tram M , Wu TH , Muttil P . A stable live bacterial vaccine. Eur J Pharm Biopharm.2016;103:109–17. doi:10.1016/j.ejpb.2016.03.027. PMID:27020530
   PubMed Web of Science ®Google Scholar
• Tonnis WF , Mensink MA , de Jager A , van der Voort Maarschalk K , Frijlink HW , Hinrichs WL . Size and molecular flexibility of sugars determine the storage stability of freeze-dried proteins. Mol Pharm. 2015;12(3):684–94. doi:10.1021/mp500423z. PMID:25581526
   PubMed Web of Science ®Google Scholar
• Bam NB , Cleland JL , Yang J , Manning MC , Carpenter JF , Kelley RF , Randolph TW . Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci. 1998;87(12):1554–9. doi:10.1021/js980175v. PMID:10189266
   PubMed Web of Science ®Google Scholar
• Jones LS , Cipolla D , Liu J , Shire SJ , Randolph TW . Investigation of protein-surfactant interactions by analytical ultracentrifugation and electron paramagnetic resonance: The use of recombinant human tissue factor as an example. Pharm Res. 1999;16(6):808–12. doi:10.1023/A:1018809632395. PMID:10397598
   PubMed Web of Science ®Google Scholar
• Kreilgaard L , Frokjaer S , Flink JM , Randolph TW , Carpenter JF . Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid. Arch Biochem Biophys. 1998;360(1):121–34. doi:10.1006/abbi.1998.0948. PMID:9826437
   PubMed Web of Science ®Google Scholar
• Prince AM , Stephan W , Kotitschke R , Brotman B . Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation. Thromb Haemost. 1983;50(2):534–6. doi:10.1006/abbi.1997.0111. PMID:6415846
   PubMed Web of Science ®Google Scholar
• Cherepova N , Veljanov D . Effect of sorbitan monolaurate polyoxyalkylene (Tween 20) on the ultrastructure of some bacteria. Cytobios. 1994;80(322):179–85. PMID:7539732
   PubMedGoogle Scholar
• Newman JF , Tirrell S , Ullman C , Piatti PG , Brown F . Stabilising oral poliovaccine at high ambient temperatures. Dev Biol Stand. 1996;87:103–11. PMID:8854007
   PubMedGoogle Scholar
• Chen CH , Wu R , Roth LG , Guillot S , Crainic R . Elucidating mechanisms of thermostabilization of poliovirus by D2O and MgCl2. Arch Biochem Biophys. 1997;342(1):108–16. PMID:9185619
   PubMed Web of Science ®Google Scholar
• Erk I , Huet JC , Duarte M , Duquerroy S , Rey F , Cohen J , Lepault J . A zinc ion controls assembly and stability of the major capsid protein of rotavirus. J Virol. 2003;77(6):3595–601. doi:10.1128/JVI.77.6.3595-3601.2003. PMID:12610135
   PubMed Web of Science ®Google Scholar
• Shirley JA , Beards GM , Thouless ME , Flewett TH . The influence of divalent cations on the stability of human rotavirus. Arch Virol. 1981;67(1):1–9. doi:10.1007/BF01314596. PMID:6263223
   PubMed Web of Science ®Google Scholar
• Turnbull AE , Skulimowski A , Smythe JA , Alexander IE . Adeno-associated virus vectors show variable dependence on divalent cations for thermostability: Implications for purification and handling. Hum Gene Ther. 2000;11(4):629–35. doi:10.1089/10430340050015815. PMID:10724041
   PubMed Web of Science ®Google Scholar
• Duddu SP , Dal Monte PR . Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody. Pharm Res. 1997;14(5):591–5. doi:10.1023/A:1012144810067. PMID:9165528
   PubMed Web of Science ®Google Scholar
• Sarciaux JM , Hageman MJ . Effects of bovine somatotropin (rbSt) concentration at different moisture levels on the physical stability of sucrose in freeze-dried rbSt/sucrose mixtures. J Pharm Sci. 1997;86(3):365–71. doi:10.1021/js960217k. PMID:9050807
   PubMed Web of Science ®Google Scholar
• Walters RH , Bhatnagar B , Tchessalov S , Izutsu K , Tsumoto K , Ohtake S . Next generation drying technologies for pharmaceutical applications. J Pharm Sci. 2014;103(9):2673–95. doi:10.1002/jps.23998. PMID:24916125
   PubMed Web of Science ®Google Scholar
• Calcott P . Implementation of quality by design in vaccine development: BioProcess international; 2013 [ cited 2013 February]. Web Article.
   Google Scholar
• Administration. UFaD . Guidance for industry: Q10 pharmaceutical cGMP regulations, US Department of Health and Human Service. Rockville (MD): FDA; September, 2006. FDA Guideline.
   Google Scholar
• Rathore AS . Roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol. 2009;27(9):546–53. doi:10.1016/j.tibtech.2009.06.006. PMID:19647883
   PubMed Web of Science ®Google Scholar
• Rathore AS , Winkle H . Quality by design for biopharmaceuticals. Nat Biotechnol. 2009;27(1):26–34. doi:10.1038/nbt0109-26. PMID:19131992
   PubMed Web of Science ®Google Scholar
• Haas J , Franklin A , Houser M , Maraldo D , Mikola M , Ortiz R , Sullivan E , Otero JM . Implementation of QbD for the development of a vaccine candidate. Vaccine. 2014;32(24):2927–30. doi:10.1016/j.vaccine.2014.02.028. PMID:24598725
   PubMed Web of Science ®Google Scholar
• group Ma , Cape S , Chaudhari A , Vaidya V , Mulay R , Agarkhedkar S , Shermer C , Collins M , Anderson R , Agarkhedkar S , et al. Safety and immunogenicity of dry powder measles vaccine administered by inhalation: A randomized controlled Phase I clinical trial. Vaccine. 2014;32(50):6791–7. doi:10.1016/j.vaccine.2014.09.071. PMID:25446830
   PubMed Web of Science ®Google Scholar
• Weniger BG , Papania MJ . 61 - Alternative vaccine delivery methods A2 - Plotkin, Stanley A. In: Orenstein WA , Offit PA , editors. Vaccines (Sixth Edition). London: W.B. Saunders; 2013. p. 1200–31.
   Google Scholar
• Satti I , Meyer J , Harris SA , Manjaly Thomas ZR , Griffiths K , Antrobus RD , Rowland R , Ramon RL , Smith M , Sheehan S , et al. Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial. Lancet Infect Dis. 2014;14(10):939–46. doi:10.1016/S1473-3099(14)70845-X. PMID:25151225
   PubMed Web of Science ®Google Scholar
• Pastor M , Esquisabel A , Talavera A , Ano G , Fernandez S , Cedre B , Infante JF , Callicó A , Pedraz JL . An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles. Int J Pharm. 2013;448(1):247–58. doi:10.1016/j.ijpharm.2013.02.057. PMID:23518363
   PubMed Web of Science ®Google Scholar
• Minne A , Louahed J , Mehauden S , Baras B , Renauld JC , Vanbever R . The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. Immunology. 2007;122(3):316–25. doi:10.1111/j.1365-2567.2007.02641.x. PMID:17521369
   PubMed Web of Science ®Google Scholar
• Holmgren J , Czerkinsky C . Mucosal immunity and vaccines. Nat Med. 2005;11(4 Suppl):S45–53. doi:10.1038/nm1213. PMID:15812489
   PubMed Web of Science ®Google Scholar
• Thomas C , Gupta V , Ahsan F . Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles. Pharm Res. 2010;27(5):905–19. doi:10.1007/s11095-010-0094-x. PMID:20232117
   PubMed Web of Science ®Google Scholar
• Lu D , Hickey AJ . Pulmonary vaccine delivery. Expert Rev Vaccines. 2007;6(2):213–26. doi:10.1586/14760584.6.2.213. PMID:17408371
   PubMed Web of Science ®Google Scholar
• Sou T , Meeusen EN , de Veer M , Morton DA , Kaminskas LM , McIntosh MP . New developments in dry powder pulmonary vaccine delivery. Trends Biotechnol. 2011;29(4):191–8. doi:10.1016/j.tibtech.2010.12.009. PMID:21255854
   PubMed Web of Science ®Google Scholar
• Frijlink HW , De Boer AH . Dry powder inhalers for pulmonary drug delivery. Expert Opin Drug Deliv. 2004;1(1):67–86. doi:10.1517/17425247.1.1.67. PMID:16296721
   PubMedGoogle Scholar
• Amorij JP , Hinrichs W , Frijlink HW , Wilschut JC , Huckriede A . Needle-free influenza vaccination. Lancet Infect Dis. 2010;10(10):699–711. doi:10.1016/S1473-3099(10)70157-2. PMID:20883966
   PubMed Web of Science ®Google Scholar
• de Boer AH , Hagedoorn P , Westerman EM , Le Brun PP , Heijerman HG , Frijlink HW . Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses. Eur J Pharm. 2006;28(3):171–8. doi:10.1016/j.ejps.2005.11.013. PMID:16650739
   PubMed Web of Science ®Google Scholar
• Hoppentocht M , Akkerman OW , Hagedoorn P , Alffenaar JW , van der Werf TS , Kerstjens HA , Frijlink HW , de Boer AH . Tolerability and pharmacokinetic evaluation of inhaled dry powder tobramycin free base in non-cystic fibrosis bronchiectasis patients. PloS One. 2016;11(3):e0149768. doi:10.1371/journal.pone.0149768. PMID:26959239
   PubMed Web of Science ®Google Scholar
• Jabbal-Gill I . Nasal vaccine innovation. J Drug Target. 2010;18(10):771–86. doi:10.3109/1061186X.2010.523790. PMID:21047271
   PubMed Web of Science ®Google Scholar
• Mutsch M , Zhou W , Rhodes P , Bopp M , Chen RT , Linder T , Spyr C , Steffen R . Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. New Engl J Med. 2004;350(9):896–903. doi:10.1056/NEJMoa030595. PMID:14985487
   PubMed Web of Science ®Google Scholar
• Tafaghodi M , Abolghasem Sajadi Tabassi S , Jaafari MR , Zakavi SR , Momen-Nejad M . Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int J Pharm. 2004;280(1–2):125–35. doi:10.1016/j.ijpharm.2004.05.009. PMID:15265553
   PubMed Web of Science ®Google Scholar
• Vidgren MT , Kublik H . Nasal delivery systems and their effect on deposition and absorption. Adv Drug Deliv Rev. 1998;29(1–2):157–77. doi:10.1016/S0169-409X(97)00067-7. PMID:10837586
   PubMed Web of Science ®Google Scholar
• Newman SP , Pitcairn GR , Dalby RN . Drug delivery to the nasal cavity: In vitro and in vivo assessment. Crit Rev Ther Drug Carrier Syst. 2004;21(1):21–66. doi:10.1615/CritRevTherDrugCarrierSyst.v21.i1.20. PMID:15099184
   PubMed Web of Science ®Google Scholar
• Ugwoke MI , Agu RU , Verbeke N , Kinget R . Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv Drug Deliv Rev. 2005;57(11):1640–65. doi:10.1016/j.addr.2005.07.009. PMID:16182408
   PubMed Web of Science ®Google Scholar
• Huang J , Mikszta JA , Ferriter MS , Jiang G , Harvey NG , Dyas B , Roy CJ , Ulrich RG , Sullivan VJ . Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge. Hum Vaccin. 2007;3(3):90–3. doi:10.4161/hv.3.3.4011. PMID:17375001
   PubMed Web of Science ®Google Scholar
• Huang J , Garmise RJ , Crowder TM , Mar K , Hwang CR , Hickey AJ , Mikszta JA , Sullivan VJ . A novel dry powder influenza vaccine and intranasal delivery technology: Induction of systemic and mucosal immune responses in rats. Vaccine. 2004;23(6):794–801. doi:10.1016/j.vaccine.2004.06.049. PMID:15542204
   PubMed Web of Science ®Google Scholar
• Garmise RJ , Staats HF , Hickey AJ . Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination. AAPS PharmSciTech. 2007;8(4):E81. doi:10.1208/pt0804081. PMID:18181542
   PubMed Web of Science ®Google Scholar
• Papania MJJJB , Bagley MC , Friets EM , Knaus DA . inventor; The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Creare Llc,, assignee. Nasal aerosol delivery system 2011.
   Google Scholar
• Patel VF , Liu F , Brown MB . Advances in oral transmucosal drug delivery. J Control Release. 2011;153(2):106–16. doi:10.1016/j.jconrel.2011.01.027. PMID:21300115
   PubMed Web of Science ®Google Scholar
• Kraan H , Vrieling H , Czerkinsky C , Jiskoot W , Kersten G , Amorij JP . Buccal and sublingual vaccine delivery. J Control Release. 2014;190:580–92. doi:10.1016/j.jconrel.2014.05.060. PMID:24911355
   PubMed Web of Science ®Google Scholar
• Kraan H , van der Stel W , Kersten G , Amorij JP . Alternative administration routes and delivery technologies for polio vaccines. Expert Rev Vaccines. 2016;15(8):1029–40. doi:10.1586/14760584.2016.1158650. PMID:26912100
   PubMed Web of Science ®Google Scholar
• Ubale RV , D'Souza MJ , Infield DT , McCarty NA , Zughaier SM . Formulation of meningococcal capsular polysaccharide vaccine-loaded microparticles with robust innate immune recognition. J Microencapsul. 2013;30(1):28–41. doi:10.3109/02652048.2012.692402. PMID:22657751
   PubMed Web of Science ®Google Scholar
• Mitragotri S . Immunization without needles. Nat Rev Immunol. 2005;5(12):905–16. doi:10.1038/nri1728. PMID:16239901
   PubMed Web of Science ®Google Scholar
• Chen D , Burger M , Chu Q , Endres R , Zuleger C , Dean H , Payne LG . Epidermal powder immunization: Cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res. 2004;103(1–2):147–53. doi:10.1016/j.virusres.2004.02.027. PMID:15163503
   PubMed Web of Science ®Google Scholar
• Dean HJ . Epidermal delivery of protein and DNA vaccines. Expert Opin Drug Deliv. 2005;2(2):227–36. doi:10.1517/17425247.2.2.227. PMID:16296750
   PubMedGoogle Scholar
• Chen D , Endres R , Maa YF , Kensil CR , Whitaker-Dowling P , Trichel A , Youngner JS , Payne LG . Epidermal powder immunization of mice and monkeys with an influenza vaccine. Vaccine. 2003;21(21–22):2830–6. doi:10.1016/S0264-410X(03)00175-0. PMID:12798624
   PubMed Web of Science ®Google Scholar
• Lycke N . Recent progress in mucosal vaccine development: Potential and limitations. Nat Rev Immunol. 2012;12(8):592–605. doi:10.1038/nri3251. PMID:22828912
   PubMed Web of Science ®Google Scholar
• Akande J , Yeboah KG , Addo RT , Siddig A , Oettinger CW , D'Souza MJ . Targeted delivery of antigens to the gut-associated lymphoid tissues: 2. Ex vivo evaluation of lectin-labelled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer's patches. J Microencapsul. 2010;27(4):325–36. doi:10.3109/02652040903191834. PMID:20055749
   PubMed Web of Science ®Google Scholar
• Wilkhu J , McNeil SE , Kirby DJ , Perrie Y . Formulation design considerations for oral vaccines. Ther Deliv. 2011;2(9):1141–64. doi:10.4155/tde.11.82. PMID:22833911
   PubMedGoogle Scholar
• Xiang SD , Scholzen A , Minigo G , David C , Apostolopoulos V , Mottram PL , Plebanski M . Pathogen recognition and development of particulate vaccines: Does size matter? Methods. 2006;40(1):1–9. doi:10.1016/j.ymeth.2006.05.016. PMID:16997708
   PubMed Web of Science ®Google Scholar
• Hori M , Onishi H , Machida Y . Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. Int J Pharm. 2005;297(1–2):223–34. doi:10.1016/j.ijpharm.2005.04.008. PMID:15885938
   PubMed Web of Science ®Google Scholar
• Chablani L , Tawde SA , D'Souza MJ . Spray-dried microparticles: A potential vehicle for oral delivery of vaccines. J Microencapsul. 2012;29:388–97. doi:10.3109/02652048.2011.651503. PMID:22283700
   PubMed Web of Science ®Google Scholar
• Shastri PN , Kim MC , Quan FS , D'Souza MJ , Kang SM . Immunogenicity and protection of oral influenza vaccines formulated into microparticles. J Pharm Sci. 2012;101(10):3623–35. doi:10.1002/jps.23220. PMID:22711602
   PubMed Web of Science ®Google Scholar
• Chablani L , Tawde SA , Akalkotkar A , D'Souza C , Selvaraj P , D'Souza MJ . Formulation and evaluation of a particulate oral breast cancer vaccine. J Pharm Sci. 2012;101(10):3661–71. doi:10.1002/jps.23275. PMID:22828873
   PubMed Web of Science ®Google Scholar
• Scherliess R , Ajmera A , Dennis M , Carroll MW , Altrichter J , Silman NJ , Scholz M , Kemter K , Marriott AC . Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates. Vaccine. 2014;32(19):2231–40. doi:10.1016/j.vaccine.2014.01.077. PMID:24631078
   PubMed Web of Science ®Google Scholar
• Siew A . Exploring the use of aseptic spray drying in the manufacture of biopharmaceutical injectables. Pharmaceutical Technology. 2016;40(7):24 -27. http://www.pharmtech.com/exploring-use-aseptic-spray-drying-manufacture-biopharmaceutical-injectables
   Google Scholar